How Biosimilar Manufacturers Can Get the Most Out of the “Patent Cliff”

Pharmaceutical Executive is a US-based trade magazine which offers strategy-based, business management content aimed at senior executives, corporate strategists and sales & marketing leaders in the global pharmaceutical industry.

With the popularity of biosimilars on the rise, it is key that manufacturers optimise every opportunity they have to differentiate their products and cultivate confidence from prospective buyers. In this article, George I’ons, Head of Product Strategy at Owen Mumford Pharmaceutical Services, discusses the five key requirements for launching a biosimilar successfully.